Bone Cancer Treatment Market Opportunity Analysis, 2016–2024
Bone Cancer Treatment Market Overview
Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which the bone tissues grows in an uncontrollable manner. This growth may be benign or malignant. In most cases bone cancer results from other cancers such as lung cancer, kidney cancer, prostate cancer, and breast cancer, which is also called secondary or metastatic bone cancer. The major and primary symptom of bone cancer is severe bone pain, which usually intensifies with time. In addition to pain, symptoms such as weight loss, fever, fatigue, muscle pain, bone crack, osteoporosis and osteopenia are also identified. Diagnosis of bone cancer includes understanding patient’s history and reasons causing pain. Besides, bone cancer can be diagnosed using imaging techniques such as computerized tomography (CT), bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and biopsy tests.
Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/93
Bone cancer treatment market can be classified on basis of type and treatment available for bone cancer
The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone cancer and secondary bone cancer. Primary bone cancer originates from fast and uncontrollable growth of the bone and other related tissues. Types of primary bone cancer include osteosarcoma, chondrosarcoma, Ewing’s sarcoma, spindle cell sarcoma, and chordoma. Secondary bone cancer, also called metastatic bone cancer, arises due to spreading of cancer cells from different parts of body. It is also referred as metastatic bone cancer.
On the basis of therapies or treatments available, the global bone cancer treatment market is classified as radiation therapy, chemotherapy, cryosurgery, and surgical treatments. The major surgical practices used to treat bone cancer are limb amputation surgery and limb salvage surgery or limb sparing surgery. In radiation therapy, high energy X-rays or gamma-rays are used to destroy tumors. Chemotherapy is a pharmacological treatment that involves the use of anti-cancer drugs. Major drugs include strontium-89 chloride, bisphosphonates, methotrexate, and doxorubicin, among others. Cryosurgery is sometimes used in lieu of conventional surgery to kill tumors.
Increasing disease incidence creating favorable growth environment for Bone cancer treatment market
Developed markets such as the U.S., U.K., Japan, Canada, Australia, Germany, and Spain have a robust healthcare infrastructure that provides patients with easy access to advanced healthcare facilities, which aids in early diagnosis of bone cancer. According to the American Cancer Society (ACS), approximately 3,300 new cases of bone cancer are expected to be diagnosed in 2016, resulting in around 1,490 deaths in the same year. Moreover, the ACS sates that in adults over 40% of primary bone cancers are chondrosarcomas. This is followed by osteosarcomas (28%), chordomas (10%), Ewing tumors (8%), and malignant fibrous histiocytoma/fibrosarcomas (4%). According to 2016 Cancer.Net estimates, 3,300 people of all ages in the U.S. would be diagnosed with primary bone cancer. New cases of bone cancer being diagnosed would propel growth of the bone cancer treatment market in the U.S. On the other hand, rising incidence rate in Asia Pacific is expected to be a major growth factor for the global bone cancer treatment market, supported by growing awareness among the populace.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/93
Global players involved in the bone cancer treatment market
Major players involved in bone cancer treatment market include Amgen Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company.
Dr. Andre Roodt, a researcher at the University of Free State has developed pain relieving drug for bone cancer patients in December 2016. The drug is a liquid radioactive isotope that can detect cancer in the body. Innovation in treatment options would lead to better therapeutic outcomes.
You may be interested
Data Loss Prevention Market: Taking New Steps to Meet the Challenges and Enter in IndustryMohit Joshi - November 12, 2018
Global Data Loss Prevention Market Provide Forecast Report 2018 presents an market Industry analysis of the report which researched industry growth, market share, size and demands over forecast period…
Virtual Reality Content Creation Market Cohesive and Predictive Business Strategy Till 2026Mohit Joshi - November 12, 2018
Global Virtual Reality Content Creation Market Provide Forecast Report 2018 presents an market Industry analysis of the report which researched industry growth, market share, size and demands over forecast…
Electrochromic Glass Market Growth Rate, Key Vendors, Trends, Drivers & Opportunities to 2026Mohit Joshi - November 12, 2018
Global Electrochromic Glass Market Provide Forecast Report 2018 presents an market Industry analysis of the report which researched industry growth, market share, size and demands over forecast period (2018-…